China Simplifies New Registration Provisions For Technology Transfers; Move Will Benefit MNCs
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - China's State FDA has released new provisions to simplify and standardize registration for drug technology transfers that will benefit multinational companies acquiring technologies in China